Oncimmune Holdings plc (LON:ONC – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 8 ($0.10) and last traded at GBX 9.95 ($0.12), with a volume of 378794 shares. The stock had previously closed at GBX 10.20 ($0.13).
Oncimmune Stock Performance
The firm has a market capitalization of £7.38 million, a PE ratio of -331.67 and a beta of 1.19. The business’s fifty day simple moving average is GBX 13.81 and its 200-day simple moving average is GBX 14.84. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 1.13.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Read More
- Five stocks we like better than Oncimmune
- 3 Small Caps With Big Return Potential
- 3 Must-Have ETFs Set to Dominate This Quarter
- CD Calculator: Certificate of Deposit Calculator
- Seeking Stability? These 3 Stocks Offer Strong Potential
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
